Beyond pharmacological management, the results might entail a further treatment option: PGC-1α is targetable by long-term physical activity[94,95] and could additionally explain advantageous impacts of physical exercise on heart failure outcome[96,97]. Here, PPARGC1A is linked to heart failure.